These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8935719)

  • 1. Chronotoxicity of sodium valproate in pregnant mouse and embryo.
    Ohdo S; Watanabe H; Ogawa N; Yoshiyama Y; Sugiyama T
    Jpn J Pharmacol; 1996 Mar; 70(3):253-8. PubMed ID: 8935719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian rhythm of embryotoxicity induced by sodium valproate in mice.
    Ohdo S; Watanabe H; Ogawa N; Yoshiyama Y; Sugiyama T
    Eur J Pharmacol; 1995 Oct; 293(3):281-5. PubMed ID: 8666048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronotoxicity of sodium valproate and its mechanisms in mice: dose-concentration-response relationship.
    Ohdo S; Nakano S; Ogawa N
    Chronobiol Int; 1989; 6(3):229-35. PubMed ID: 2509086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronopharmacological study of sodium valproate in mice: dose-concentration-response relationship.
    Ohdo S; Nakano S; Ogawa N
    Jpn J Pharmacol; 1988 May; 47(1):11-9. PubMed ID: 3137385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronopharmacological study of valproic acid in mice: comparison of oral and rectal administration.
    Yoshiyama Y; Nakano S; Ohdo S; Ogawa N
    J Pharmacobiodyn; 1992 Aug; 15(8):403-8. PubMed ID: 1479540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid teratogenicity in mice after various administration and phenobarbital-pretreatment regimens: the parent drug and not one of the metabolites assayed is implicated as teratogen.
    Nau H
    Fundam Appl Toxicol; 1986 May; 6(4):662-8. PubMed ID: 3086173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effect of polyunsaturated fatty acid intake during pregnancy against embryotoxicity of sodium valproate in mice.
    Li K; Li J; Gu J; Guo X; Gao T; Li D
    Food Funct; 2018 May; 9(5):2634-2643. PubMed ID: 29561026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of an in vitro teratology system using chiral substances: stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos.
    Andrews JE; Ebron-McCoy M; Bojic U; Nau H; Kavlock RJ
    Toxicol Appl Pharmacol; 1995 Jun; 132(2):310-6. PubMed ID: 7785058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of embryotoxicity using mouse embryo culture.
    Winn LM; Tung EW
    Methods Mol Biol; 2009; 550():241-9. PubMed ID: 19495708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
    Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
    Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolite profiling of whole murine embryos reveals metabolic perturbations associated with maternal valproate-induced neural tube closure defects.
    Akimova D; Wlodarczyk BJ; Lin Y; Ross ME; Finnell RH; Chen Q; Gross SS
    Birth Defects Res; 2017 Jan; 109(2):106-119. PubMed ID: 27860192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid-induced gene expression responses in rat whole embryo culture and comparison across in vitro developmental and non-developmental models.
    Tonk EC; Robinson JF; Verhoef A; Theunissen PT; Pennings JL; Piersma AH
    Reprod Toxicol; 2013 Nov; 41():57-66. PubMed ID: 23811354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian variation of Valproic acid pharmacokinetics in mice.
    Ben-Cherif W; Dridi I; Aouam K; Ben-Attia M; Reinberg A; Boughattas NA
    Eur J Pharm Sci; 2013 Jul; 49(4):468-73. PubMed ID: 23707469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid alters nitric oxide status in neurulating mouse embryos.
    Tiboni GM; Ponzano A; Ferrone A; Franceschelli S; Speranza L; Patruno A
    Reprod Toxicol; 2021 Jan; 99():152-159. PubMed ID: 33157224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice.
    Elmazar MM; Thiel R; Nau H
    Fundam Appl Toxicol; 1992 Apr; 18(3):389-94. PubMed ID: 1597263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in culture.
    Bruckner A; Lee YJ; O'Shea KS; Henneberry RC
    Teratology; 1983 Feb; 27(1):29-42. PubMed ID: 6405496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the human teratogenic potential of the anticonvulsant, valproic acid, from a non-human primate model.
    Mast TJ; Cukierski MA; Nau H; Hendrickx AG
    Toxicology; 1986 May; 39(2):111-9. PubMed ID: 3085290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronopharmacokinetics of valproic acid following constant-rate administration in mice.
    Ohdo S; Nakano S; Ogawa N
    Chronobiol Int; 1991 Feb; 8(1):35-43. PubMed ID: 1814601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified Xenopus laevis approach (R-FETAX) as an alternative test for the evaluation of foetal valproate spectrum disorder.
    Battistoni M; Bacchetta R; Di Renzo F; Metruccio F; Moretto A; Menegola E
    Reprod Toxicol; 2022 Jan; 107():140-149. PubMed ID: 34923091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.